Completeness of hospital cancer case reporting from the SEER program of the national cancer institute

Abstract

Background. To ascertain the quality of data entering a population‐based reporting system, an essential requirement is to study levels of completeness of case‐ascertainment and reporting. This study represents an effort to quantify completeness of case reporting in the SEER (Surveillance, Epidemiology, and End Results) Program of the National Cancer Institute. Methods. Hospitals in each of the participating SEER areas were stratified according to their annual hospital cancer caseload for the year 1987. Within each caseload stratum, a random sample of hospitals was selected for inclusion in this study. Files in the medical record, pathology, and radiation oncology departments in each hospital were reviewed for SEER reportable cases. These cases were then matched against SEER case listings to identify unreported cases. Results. The crude estimated completeness of reporting for 1987 in the six participating SEER areas was 97.7% and the registry‐caseload standardized rate was 96.8%. Variation was noted by SEER registry, hospital cancer caseload, and casefinding source (hospital department). Three‐quarters of unreported cases were of invasive disease and one‐fourth were in situ, primarily of the cervix uteri. Conclusions. There is variation in completeness of casefinding among SEER registries, hospital size, and hospital department source. Additional factors that appear to be related to case ascertainment are cancer site or type and who performs the casefinding function (hospital registry or central registry staff). Cancer 1995; 76:2343–50.

Incidence of eye cancer in Taiwan: an 18-year review

“…This compares favourably with the cancer registries in other developed countries. 14 Based on three data profiles from the Taiwan Cancer Registry, death certificate data from the government's Department of Health, and the Catastrophic Illness Registry in the Taiwan National Health Insurance Program, the 31 this may be regarded as a minimum estimate, because missed cases subsequently identified by continuing surveillance would be asked to report to the registry system. Moreover, the Taiwan Cancer Registry is believed to be more complete especially in recent years, as medical-care access is no longer a problem since the implementation of the National Health Insurance Program.…”

Relative survival of childhood and adult medulloblastomas and primitive neuroectodermal tumors (PNETs)

“…It has a previously reported (when it covered 14% of the US population) 97.7 case ascertainment rate, indicating that only an estimated 2.3% of cancers have been missed, which is impressive for such a large population-based database. 15 Its ascertainment of radiation oncology records is approximately 99%.…”

Ethnic variations in diagnosis, treatment, socioeconomic status, and survival in a large population‐based cohort of elderly patients with non‐Hodgkin lymphoma

“…24,25 The SEER program, supported by the National Cancer Institute, consists of population-based tumor registries that collect standardized information on all cancers diagnosed within the specified geographic regions. [24][25][26][27] The metropolitan areas of San Francisco/Oakland, Detroit, Atlanta, and Seattle; Los Angeles County; the San Jose-Monterey area; and the states of Connecticut, Iowa, New Mexico, Utah, and Hawaii were included in this report. The Medicare component, conversely, is the primary health insurer for the great majority of the US population 65 years of age.…”